Growth Hormone Secretion Following the Anaerobic Exercise

Status Recruiting

Clinical Trial Summary

Proper growth in children is a complex process regulated by a combination of genetic, nutritional, environmental, hormonal, and others. Growth hormone (GH) is the main hormone regulating the growth from childhood to adulthood. Despite great progress in the field, with the development of recombinant GH for the treatment of growth hormone deficiency (GHD), there is still no reliable method for testing GHD. Physical exertion is one of the significant physiologic stimuli for GH secretion, and it is reliable test for identification of GHD. It is not in use in the clinics because of its complexity. Recently GH secretion following short anaerobic exercise in young adults was tested and also demonstrated significant growth hormone secretion

In contrast to adult children's exercise is characterized by an anaerobic nature. There is no data about secretion of growth hormone in response to anaerobic exercise in children.

Purpose of the experiment:

The purpose of this study is to evaluate the secretion of growth hormone in response to anaerobic exercise in children.

Clinical Trial Description

100 children aged 6-16 years, followed at the pediatric endocrinology clinic for growth assessment or obesity. Assessment of their growth hormone axis will be evaluate in parallel according to the currently accepted pharmacological GH testing as accepted and also following anaerobic physical test.

After explanation to the patient and his parent and obtaining an informed consent, the children will be instructed to pedal at maximum speed for 15 seconds x 10 sprints (1 minute of recovery between the sprints) against a resistance adjusted according to their body mass index.

The test will perform in similarity to GH provocative protocols by mean that they will be performed in the morning after a night's sleep and overnight fasting. The patients will be remained fasting during the test.

They will be asked not to exercise a day before the test. Thirty minutes before the test, Venflon will be inserted and the child will receive an explanation and rest until the beginning of the test. blood GH, IGF-1, cortisol will be taken at the beginning of exercise (time 0), at the end of exercise, after 30 minutes, 45 minutes and 60 minutes is customary according to criteria set pharmacological inventory growth hormone.

The test results will be compared to pharmacological testing of the child if available. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01934270
Study type	Interventional
Source	Meir Medical Center
Contact
Status	Recruiting
Phase	N/A
Start date	May 2014
Completion date	March 1, 2020

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT03994419` - PErioperAtive CHildhood ObesitY
Active, not recruiting	`NCT06259539` - A YouTube Curriculum for Children With Autism and Obesity	N/A
Completed	`NCT03533621` - Gut Microbiome, Adiposity, and Probiotics (GMAP)	N/A
Completed	`NCT03641521` - A Trial to Increase Child Vegetable Intake Through Behavioral Strategies	N/A
Completed	`NCT04009304` - Effective Training Models for Implementing Health-Promoting Practices Afterschool	N/A
Recruiting	`NCT05563311` - Functional Assessment and Sleep Apnea in Obese Children and Adolescents	N/A
Completed	`NCT03575884` - Fit 5 Kids Screen Time Reduction Curriculum for Latino Preschoolers	N/A
Terminated	`NCT03586544` - Reducing Exercise-induced Bronchoconstriction in Children With Asthma and Obesity	Phase 4
Completed	`NCT04628897` - Physical Activity and the Home Environment in Preschool-aged Children in Urban Bangladesh
Completed	`NCT03399617` - SPOON: Sustained Program for Improving Nutrition - Guatemala	N/A
Enrolling by invitation	`NCT06265597` - The Effect of Healthy Nutrition and Yoga Program on Obese Children	N/A
Active, not recruiting	`NCT03843424` - Treatment Efforts Addressing Child Weight Management by Unifying Patients, Parents & Providers	N/A
Completed	`NCT03170700` - Online Videos and New Feeding Content to Enhance a Current EFNEP Program	N/A
Enrolling by invitation	`NCT05551650` - El Sendero: Pathways to Health Study
Completed	`NCT04346433` - Sleep and Stigma: Novel Moderators in the Relationship Between Weight Status and Cognitive Function	N/A
Recruiting	`NCT03963557` - Cognitive Function and Body Mass Index in Children and Adolescents
Completed	`NCT03495310` - Effect of Mindfulness on Stress, Appetite Hormones and Body Weight of Obese Schoolchildren. Controlled Clinical Trial	N/A
Recruiting	`NCT06028113` - A Novel Obesity Prevention Program for High-Risk Infants in Primary Care	Phase 2
Active, not recruiting	`NCT05465057` - "HIIT Med Kiloene".	N/A
Completed	`NCT03069274` - Sugar-sweetened Beverage Intake Substitution by Water to Prevent Overweight in Mexican Children	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.